Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Etifoxine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Etifoxine, including repackagers and relabelers. The FDA regulates Etifoxine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Etifoxine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Etifoxine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Etifoxine supplier is an individual or a company that provides Etifoxine active pharmaceutical ingredient (API) or Etifoxine finished formulations upon request. The Etifoxine suppliers may include Etifoxine API manufacturers, exporters, distributors and traders.
click here to find a list of Etifoxine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Etifoxine written confirmation (Etifoxine WC) is an official document issued by a regulatory agency to a Etifoxine manufacturer, verifying that the manufacturing facility of a Etifoxine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Etifoxine APIs or Etifoxine finished pharmaceutical products to another nation, regulatory agencies frequently require a Etifoxine WC (written confirmation) as part of the regulatory process.
click here to find a list of Etifoxine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Etifoxine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Etifoxine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Etifoxine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Etifoxine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Etifoxine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Etifoxine suppliers with NDC on PharmaCompass.
Etifoxine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Etifoxine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Etifoxine GMP manufacturer or Etifoxine GMP API supplier for your needs.
A Etifoxine CoA (Certificate of Analysis) is a formal document that attests to Etifoxine's compliance with Etifoxine specifications and serves as a tool for batch-level quality control.
Etifoxine CoA mostly includes findings from lab analyses of a specific batch. For each Etifoxine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Etifoxine may be tested according to a variety of international standards, such as European Pharmacopoeia (Etifoxine EP), Etifoxine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Etifoxine USP).
LOOKING FOR A SUPPLIER?
